The AeroEclipse® XL Breath Actuated Nebulizer (BAN) represents a significant advancement in aerosol therapy, designed to maximize medication delivery to the lungs while minimizing waste and environmental exposure. Its core innovation lies in its breath-actuated technology, ensuring medication is released only when the patient inhales.

 Features:

• Intelligent Breath-Actuated Delivery: This primary feature synchronizes aerosol production with the patient's inspiratory effort, ensuring a higher percentage of the medication reaches the lungs and reducing drug loss during exhalation or pauses in treatment.
• Enhanced Environmental Safety: By limiting aerosol generation to the inhalation phase, the AeroEclipse® XL BAN significantly reduces the release of potentially harmful drug particles into the surrounding air, contributing to a safer clinical or home environment for everyone.
• Visual Inhalation Guidance & Flexible Operation: The integrated green feedback button provides real-time confirmation of proper inhalation technique, encouraging slow and deep breaths for optimal drug delivery. Additionally, a mode selector allows for switching between breath-actuated and continuous nebulization, offering versatility to meet individual patient needs.
• User-Friendly Components for Easy Handling: Featuring the convenient EZ Twist tubing, connecting and disconnecting the nebulizer from the compressor is a simple and secure process. The optional ComfortSeal® Mask provides a gentle and effective seal for patients who prefer a mask, ensuring comfortable and efficient therapy.
• Designed for Extended and Safe Single-Patient Use: Constructed from BPA- and latex-free materials, the AeroEclipse® XL BAN is approved for up to six months of single-patient use, providing a durable, safe, and cost-effective solution for long-term respiratory management.